Eagle Pharmaceuticals (EGRX)

Eagle Pharmaceuticals Inc (EGRX) Q3 2020 Earnings Call Transcript
Nov. 2, 2020 | Price: Free! | Source: Motley Fool

Eagle Pharmaceuticals, Inc. (EGRX) CEO Scott Tarriff on Q3 2020 Results - Earnings Call Transcript
Nov. 2, 2020 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals Inc (EGRX) Q2 2020 Earnings Call Transcript
Aug. 10, 2020 | Price: Free! | Source: Motley Fool

Eagle Pharmaceuticals, Inc. (EGRX) CEO Scott Tarriff on Q2 2020 Results - Earnings Call Transcript
Aug. 10, 2020 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals Inc (EGRX) Q1 2020 Earnings Call Transcript
May 11, 2020 | Price: Free! | Source: Motley Fool

Eagle Pharmaceuticals, Inc. (EGRX) CEO Scott Tarriff on Q1 2020 Results - Earnings Call Transcript
May 11, 2020 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals Inc (EGRX) Q4 2019 Earnings Call Transcript
March 2, 2020 | Price: Free! | Source: Motley Fool

Eagle Pharmaceuticals, Inc. (EGRX) CEO Scott Tarriff on Q4 2019 Results - Earnings Call Transcript
March 2, 2020 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals Inc (EGRX) Q3 2019 Earnings Call Transcript
Nov. 12, 2019 | Price: Free! | Source: Motley Fool

Eagle Pharmaceuticals, Inc. (EGRX) CEO Scott Tarriff on Q3 2019 Results - Earnings Call Transcript
Nov. 12, 2019 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals Inc (EGRX) Q2 2019 Earnings Call Transcript
Aug. 9, 2019 | Price: Free! | Source: Motley Fool

Eagle Pharmaceuticals, Inc. (EGRX) CEO Scott Tarriff on Q2 2019 Results - Earnings Call Transcript
Aug. 9, 2019 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals' (EGRX) CEO Scott Tarriff on Q1 2019 Results - Earnings Call Transcript
May 7, 2019 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals' (EGRX) CEO Scott Tarriff on Q4 2018 Results - Earnings Call Transcript
Feb. 28, 2019 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals Inc. (EGRX) CEO Scott Tarriff on Q3 2018 Results - Earnings Call Transcript
Nov. 1, 2018 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals Inc. (EGRX) CEO Scott Tarriff on Q2 2018 Results - Earnings Call Transcript
Aug. 7, 2018 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals' (EGRX) CEO Scott Tarriff on Q1 2018 Results - Earnings Call Transcript
May 10, 2018 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals' (EGRX) CEO Scott Tarriff on Q4 2017 Results - Earnings Call Transcript
Feb. 26, 2018 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals' (EGRX) CEO Scott Tarriff on Q3 2017 Results - Earnings Call Transcript
Nov. 8, 2017 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals' (EGRX) CEO Scott Tarriff on Q2 2017 Results - Earnings Call Transcript
Aug. 9, 2017 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals' (EGRX) CEO Scott Tarriff on Q1 2017 Results - Earnings Call Transcript
May 8, 2017 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals' (EGRX) CEO Scott Tarriff on Q4 2016 Results - Earnings Call Transcript
March 1, 2017 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals' (EGRX) CEO Scott Tarriff on Q3 2016 Results - Earnings Call Transcript
Nov. 9, 2016 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals' (EGRX) CEO Scott Tarriff on Q2 2016 Results - Earnings Call Transcript
Aug. 9, 2016 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals' (EGRX) CEO Scott Tarriff on Q1 2016 Results - Earnings Call Transcript
May 9, 2016 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals' (EGRX) CEO Scott Tarriff on Q4 2015 Results - Earnings Call Transcript
Feb. 25, 2016 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals' (EGRX) CEO Scott Tarriff on Q3 2015 Results - Earnings Call Transcript
Nov. 11, 2015 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals' (EGRX) CEO Scott Tarriff on Q2 2015 Results - Earnings Call Transcript
Aug. 11, 2015 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals' (EGRX) CEO Scott Tarriff on Q1 2015 Results - Earnings Call Transcript
May 18, 2015 | Price: Free! | Source: Seeking Alpha

Eagle Pharmaceuticals' (EGRX) CEO Scott Tarriff on Q4 2014 Results - Earnings Call Transcript
Dec. 17, 2014 | Price: Free! | Source: Seeking Alpha

Recent filings

Steven Boyd just provided an update on share ownership of Eagle Pharmaceuticals - Feb. 16, 2021

Michael Graves just provided an update on share ownership of Eagle Pharmaceuticals - Feb. 16, 2021

Janus Henderson Group plc just provided an update on share ownership of Eagle Pharmaceuticals - Feb. 11, 2021

Statement of acquisition of beneficial ownership by individuals - Feb. 8, 2021

Departure of Directors or Certain - Feb. 8, 2021

Eagle Pharmaceuticals's Pres & Chief Operating Officer just picked up 9,700 shares - Feb. 4, 2021

Eagle Pharmaceuticals director was just granted 13,500 options - Feb. 4, 2021

Eagle Pharmaceuticals director was just granted 13,500 options - Feb. 4, 2021

Eagle Pharmaceuticals director was just granted 13,500 options - Feb. 4, 2021

Eagle Pharmaceuticals's Chief Financial Officer just picked up 8,900 shares - Feb. 4, 2021

Eagle Pharmaceuticals director was just granted 13,500 options - Feb. 4, 2021

Eagle Pharmaceuticals director was just granted 13,500 options - Feb. 4, 2021

Eagle Pharmaceuticals's Chief Medical Officer just picked up 2,000 shares - Feb. 4, 2021

Eagle Pharmaceuticals's Chief Financial Officer just disposed of 637 shares - Feb. 2, 2021

Eagle: Receives Additional Fda Questions Regarding Vasopressin; Court Date Set For July 7, 2021 In Vasopressin Trial - Feb. 2, 2021

Eagle: Draft Not For Immediate Release - Feb. 1, 2021

Eagle Pharmaceuticals's Pres & Chief Operating Officer just disposed of 1,892 shares - Jan. 26, 2021

BlackRock, Inc. just provided an update on share ownership of Eagle Pharmaceuticals - Jan. 26, 2021

Major owner of Eagle Pharmaceuticals just disposed of 4,631 shares - Jan. 26, 2021

Eagle Pharmaceuticals's Chief Financial Officer just picked up 5,000 shares - Jan. 22, 2021

1 Confidential © 2021 Eagle Pharmaceuticals, Inc. All Rights Reserved. January 2021 - Jan. 13, 2021

Eagle Pharmaceuticals's Chief Financial Officer just disposed of 237 shares - Jan. 11, 2021

Eagle Pharmaceuticals's Pres & Chief Operating Officer just disposed of 906 shares - Jan. 11, 2021

Eagle Pharmaceuticals's Chief Financial Officer just disposed of 746 shares - Jan. 7, 2021

Eagle Pharmaceuticals's Pres & Chief Operating Officer just disposed of 2,088 shares - Jan. 7, 2021

Election of - Dec. 28, 2020

Sorry, no schedule available for this company

Eagle Pharmaceuticals to Host Fourth Quarter and Full Year 2020 Financial Results and Pipeline Review on March 2, 2021 - Feb. 22, 2021

Eagle Pharmaceuticals Receives Additional FDA Questions Regarding Vasopressin; Court Date Set for July 7, 2021 in Vasopressin Trial - Feb. 2, 2021

Eagle Pharmaceuticals Announces Update in Vasopressin Trial; Trial Date Postponed - Feb. 1, 2021

Eagle Pharmaceuticals Announces Update in Vasopressin Trial; Trial Date Postponed from January 11, 2021 to February 1, 2021 to Protect Against COVID-19 Concerns - Jan. 11, 2021

Eagle Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference - Jan. 4, 2021

Eagle Pharmaceuticals’ Presentation at Piper Sandler 32nd Annual Virtual Healthcare Conference Available for Viewing - Nov. 23, 2020

Eagle Pharmaceuticals Strengthens Management Team to Prepare for Future Growth - Nov. 2, 2020

Eagle Pharmaceuticals Reports Third Quarter 2020 Results - Nov. 2, 2020

Eagle Pharmaceuticals to Discuss Third Quarter 2020 Financial Results on November 2, 2020 - Oct. 26, 2020

Eagle Pharmaceuticals Commences $25 Million Accelerated Share Repurchase as Part of Existing $160 Million Share Repurchase Program - Sept. 24, 2020

Eagle Pharmaceuticals’ Japanese Licensing Partner, SymBio, Receives Approval of TREAKISYM Ready-To-Dilute (“RTD”) Formulation, with Launch Expected in January 2021 - Sept. 23, 2020

Eagle Pharmaceuticals to Present at Upcoming September 2020 Healthcare Conferences - Sept. 8, 2020

Eagle Pharmaceuticals Announces Publication of Preclinical Study of Intranasal Dantrolene in Journal of Alzheimer’s Disease - Aug. 19, 2020

Eagle Pharmaceuticals Reports Second Quarter 2020 Results - Aug. 10, 2020

Eagle Pharmaceuticals to Discuss Second Quarter 2020 Financial Results on August 10, 2020 - Aug. 3, 2020

CMS Establishes Unique J-Code for Eagle Pharmaceuticals’ PEMFEXY™ (Pemetrexed for Injection) - July 9, 2020

 


Feedback